Tumor-targeted nanoparticle delivery of gene editing therapy for breast cancer

DISEASE CATEGORY: Cancer

INDICATION: Breast Cancer

A tumor-directed nanoparticle delivering CRISPR payloads targeting oncogene LCN2 could treat triple-negative

Read the full 172 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE